US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NASDAQ
Kura Oncology Inc (KURA)
Kura Oncology Inc (KURA) ニュース

Kura Oncology Inc (KURA)

11.45

-0.63

(-5.22%)

終了 7月12日 5:00AM

11.50

0.05

(0.44%)

取引時間後: 8:59AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, July 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML

– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007...

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy

– Preliminary Phase 1a data from darlifarnib + adagrasib demonstrate confirmed, objective response rates of 67...

Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML

– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

– Tumor shrinkage observed in 77% of response-evaluable patients, including in heavily pretreated and...

Form 4 - Statement of changes in beneficial ownership of securities

iHub News

iHub News 3月前

Kura Oncology Shares Jump on Encouraging Kidney Cancer Trial ResultsApril 17, 2026 8:29 AM
IH Market News
Kura Oncology (NASDAQ:KURA) shares climbed 9% on Friday after the company released early clinical data indicating its drug combination showed promising activity in patients with clear cell renal cell carcinoma who had previously been treated with cabozantinib.The company disclosed findings from a subset of its FIT-001 trial, which is assessing darlifarnib in combination with cabozantinib. Results showed an objective response rate of 44% and a disease control rate of 94% among ccRCC patients previously exposed to cabozantinib, with 75% of patients experiencing tumor shrinkage.The analysis included 16 patients with ccRCC who had already undergone treatment with cabozantinib. Treatment durations ranged between 8 and 56 weeks, with six patients still receiving therapy at the time of the data cutoff. Responses were observed even in heavily pretreated individuals, including those who had previously achieved only stable disease on cabozantinib.The data were presented at the International Kidney Cancer Symposium: Europe 2026 in Paris on April 17, 2026. The company said the treatment combination showed a manageable safety profile across different dosing levels.The ongoing FIT-001 study is testing darlifarnib at once-daily doses of 3 mg, 5 mg, or 8 mg on a 7-days-on, 7-days-off schedule, alongside cabozantinib given daily at 60 mg or 40 mg. All participants must have previously received immunotherapy, and the trial has now progressed into its Phase 1b dose expansion stage.Kura Oncology stock price

Original: Kura Oncology Shares Jump on Encouraging Kidney Cancer Trial Results

VanGan

Worth buying or better to wait until they start reporting revenue?

Monksdream

Monksdream 2年前

KURA rangebound

Invest-in-America

Invest-in-America 2年前

KURA: Yep! I noticed that too, Boss. But THANKS for your alerts about this!! (Maybe if they PR within the next hour that they are WITHDRAWING their planned shares-dump, the price will SOAR anyway!!!)

TheFinalCD

TheFinalCD 2年前

25.94 to $19.00 and the previous close was 18.60

so +.40 on that news

SMH

welcome to investing 2024

Invest-in-America

Invest-in-America 2年前

KURA: Are you frickin' KIDDING ME with this news, KURA Firm???????!!!!!!!!!

TheFinalCD

TheFinalCD 2年前

KURA NEWS https://www.globenewswire.com/news-release/2024/01/30/2819799/35186/en/Kura-Oncology-Reports-Positive-Preliminary-Ziftomenib-Combination-Data-in-Acute-Myeloid-Leukemia.html

TheFinalCD

TheFinalCD 2年前

Kura Oncology Announces Oversubscribed $150 Million Private Placement

ClayTrader

ClayTrader 6年前

* * $KURA Video Chart 04-28-2020 * *

Link to Video - click here to watch the technical chart video

seppi08162

seppi08162 7年前

Anybody out there? !

stocktrademan

stocktrademan 8年前

KURA buy 19.00

normal chart

log chart

Lone Wolf

Lone Wolf 9年前

Feels risky here...feels like they're purposely notching it down a bit and ten gapping it back up above $13...wonder which side of the market incurs the greater risk if they continue to do so?!?

Lone Wolf

Lone Wolf 9年前

Looks like the markets are really starting to feel the bio-techs again. Yesterday and today NLNK. The day before there was some other who's ticket I forget at the moment. Today KURA. Very interesting.

jr525

Just got in hope not to late

Lone Wolf

Lone Wolf 9年前

Looking KBIO-like squeezish!!

Lone Wolf

Lone Wolf 9年前

Why's that? Now it's up 60%!

sorkin

May go for a ride during regular hours

sorkin

Don't get sucked in buying this @30% premium here. Secondaries $6.5 will be selling on this spike

Bearly Bullish

Bearly Bullish 9年前

$kura long@ 8.28

stocktrademan

stocktrademan 9年前

KURA bullish 10.10

inverted head and shoulders bottom
http://www.google.com/search?q=inverted+head+and+shoulders+bottom

normal chart

log chart

ClearlyStocks

ClearlyStocks 10年前

ClearlyStocks

ClearlyStocks 10年前

ClearlyStocks

ClearlyStocks 10年前

KURA $5.66 on radar

stock_observer_77

stock_observer_77 10年前

Getting close - watch for the turn up

ClayTrader

ClayTrader 10年前

* * $KURA Video Chart 08-11-16 * *

Link to Video - click here to watch the technical chart video

INTL

Goldmind

Goldmind 10年前

$13,000 for me:)

Goldmind

Goldmind 10年前

logic_guy

logic_guy 10年前

logic_guy

logic_guy 10年前

Thanks - sold in the pre market today - Nice chunk of change 3.80s to 4.70

stock_observer_77

stock_observer_77 10年前

logic_guy

logic_guy 10年前

http://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+0810%3A+(KURA)+(ANW)+(CHK)+Higher%3B+(AVGR)+(OMER)+(SHAK)+Lower+(more...)/11926857.html

logic_guy

logic_guy 10年前

My average in the 3.80s had paid off - Nice after hours action on earnings upto 6.50 earlier high on July 15!

ClearlyStocks

ClearlyStocks 10年前

Wow. Run on earnings

stocktrademan

stocktrademan 10年前

KURA bullish 4.06

logic_guy

logic_guy 10年前

Kura back to green after a few days rest from 6.50

logic_guy

logic_guy 10年前

Took a pos at 3.90 again for a rebound back to the 5s

logic_guy

logic_guy 10年前

Hard to catch optt at 14.60s but she is trying lol

logic_guy

logic_guy 10年前

only problem is optt has 2m float this one in the tens of M range

ClearlyStocks

ClearlyStocks 10年前

TheFinalCD

TheFinalCD 10年前

logic_guy

logic_guy 10年前

Should take inspi from optt lol

ClearlyStocks

ClearlyStocks 10年前

$4.95 from $4.30 call. Breaks $5 and flies

stocktrademan

stocktrademan 10年前

KURA bullish 4.69

bull flag

logic_guy

logic_guy 10年前

6.50 was the earlier high on July 15.. Should reach at least 6 this time

ClearlyStocks

ClearlyStocks 10年前

Nice!!!! Congrats

logic_guy

logic_guy 10年前

Wow KURA is following OPTT rise ---
What a coincidence ! - My price in was 4.299 lol
07/19/2016 10:20:24 Bought ???? KURA @ 4.2999

ClearlyStocks

ClearlyStocks 10年前

ClearlyStocks

ClearlyStocks 10年前

About to go again

Warchest

Warchest 10年前

trying to extend that chart cant do much more without a dip

Bmo Global Dividend Fund...

Ci Global Bond Currency ...

Aiera Share Cls Lvl Pref...

Deutsche Telekom Interna...

INSTONE REAL ESTGRP

Schlatter Industries

Accl Fxd Cpn Nts Lkd Mei...

Bmo Monthly High Income ...

Fidelity Series Sustaina...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。